أعرض في EDS

Supplementary_Section_30Oct2018 – Supplemental material for Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study

التفاصيل البيبلوغرافية
العنوان:	Supplementary_Section_30Oct2018 – Supplemental material for Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study
المؤلفون:	Bessette, Louis, Boulos Haraoui, Chow, Andrew, Fortin, Isabelle, Dixit, Sanjay, Khraishi, Majed, Haaland, Derek, Elmoufti, Sami, Staelens, Fabienne, Bogatyreva, Irina, Syrotuik, Jerry, Shaikh, Saeed
بيانات النشر:	SAGE Journals, 2019.
سنة النشر:	2019
مصطلحات موضوعية:	FOS: Clinical medicine, 110604 Sports Medicine, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 110314 Orthopaedics
الوصف:	Supplemental material, Supplementary_Section_30Oct2018 for Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study by Louis Bessette, Boulos Haraoui, Andrew Chow, Isabelle Fortin, Sanjay Dixit, Majed Khraishi, Derek Haaland, Sami Elmoufti, Fabienne Staelens, Irina Bogatyreva, Jerry Syrotuik and Saeed Shaikh in Therapeutic Advances in Musculoskeletal Disease
DOI:	10.25384/sage.7808048
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09825d3dc6e2d01e1dc6a6bbb69f4073
رقم الأكسشن:	edsair.doi.dedup.....09825d3dc6e2d01e1dc6a6bbb69f4073
قاعدة البيانات:	OpenAIRE

الوصف
DOI:	10.25384/sage.7808048